Returns Chart

Key Stats

Net Expense Ratio Total Assets Under Management Weighted Average Dividend Yield Turnover Ratio (Generic)
0.68% 65.45M 1.98% 3.93%
1 Year Fund Level Flows 1 Year Total Returns (Daily) Annualized Total Returns Since Inception (Daily) Max Drawdown (Since Inception)
23.62M 11.07%

Basic Info

Investment Strategy
The Fund seeks a similar return to its underlying fund, which is also managed by Fidelity, by investing substantially all of its assets in securities of that underlying fund. The underlying fund seeks to replicate, to the extent reasonably possible and before fees and expenses, the performance of the Fidelity Canada International High Quality Index. The underlying fund invests primarily in equity securities of large and mid-capitalization foreign companies that have their principal business activities or interests outside of Canada or the U.S. with a higher quality profile than the broader developed international equity market.
General
Security Type Mutual Fund
Equity Style Multi Cap Growth
Broad Asset Class International Equity
Broad Category Equity
Global Peer Group Equity Global ex US
Peer Group International Equity
Global Macro Equity Global
US Macro --
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective --
Fund Owner Firm Name Fidelity Investments
Broad Asset Class Benchmark Index
^SPTSX60TR 100.0%

View Basic Info
Start Trial

Net Fund Flows Versus Peer Group

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: 32
-195.86M Peer Group Low
763.37M Peer Group High
1 Year
% Rank: 27
23.62M
-2.040B Peer Group Low
5.207B Peer Group High
3 Months
% Rank: 43
-247.05M Peer Group Low
1.824B Peer Group High
3 Years
% Rank: 33
-3.439B Peer Group Low
7.915B Peer Group High
6 Months
% Rank: 25
-599.33M Peer Group Low
3.171B Peer Group High
5 Years
% Rank: 31
-3.050B Peer Group Low
9.457B Peer Group High
YTD
% Rank: --
-195.86M Peer Group Low
763.37M Peer Group High
10 Years
% Rank: 31
-3.734B Peer Group Low
12.50B Peer Group High
Date Unavailable

Performance Versus Peer Group

 
20%
15%
10%
5%
0
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (NAV)
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
Peer Group Rtn. (NAV)
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
12.00%
% Rank in Peer Group (NAV)
5.0
5.0
5.0
5.0
5.0
5.0
5.0
5.0
View Performance Versus Peer Group
Start Trial

Annual Total Returns Versus Peers

Loading chart...
Name
2019
2020
2021
2022
2023
2024
2025
YTD
--
25.29%
5.07%
-16.49%
17.54%
10.99%
14.78%
4.16%
21.93%
5.56%
28.04%
-6.24%
12.05%
21.04%
29.06%
3.28%
15.62%
13.63%
10.08%
-16.12%
14.09%
13.64%
11.72%
2.30%
7.81%
-5.01%
12.78%
-15.30%
11.47%
16.41%
17.65%
4.00%
27.43%
11.46%
17.04%
-16.13%
18.43%
6.47%
-0.41%
0.07%
27.13%
14.75%
14.06%
-18.25%
17.85%
13.61%
12.25%
6.48%
As of February 14, 2026.

Fundamentals

General
Distribution Yield --
Dividend Yield TTM (2-13-26) 1.06%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings 119
Stock
Weighted Average PE Ratio 27.64
Weighted Average Price to Sales Ratio 6.755
Weighted Average Price to Book Ratio 8.438
Weighted Median ROE 111.7%
Weighted Median ROA 15.67%
ROI (TTM) 24.86%
Return on Investment (TTM) 24.86%
Earning Yield 0.0444
LT Debt / Shareholders Equity 0.5374
Number of Equity Holdings 90
As of December 31, 2025

Growth Metrics

EPS Growth (1Y) 16.98%
EPS Growth (3Y) 18.23%
EPS Growth (5Y) 18.39%
Sales Growth (1Y) 11.17%
Sales Growth (3Y) 10.12%
Sales Growth (5Y) 9.22%
Sales per Share Growth (1Y) 12.45%
Sales per Share Growth (3Y) 11.29%
Operating Cash Flow - Growth Rate (3Y) 13.07%
As of December 31, 2025

Asset Allocation

As of December 31, 2025.
Type % Net
Cash 0.26%
Stock 99.54%
Bond 0.01%
Convertible 0.00%
Preferred 0.00%
Other 0.19%
View Asset Allocation
Start Trial

Top 10 Holdings

Name % Weight Price % Change
ASML Holding NV 3.08% 1408.70 -0.48%
Advantest Corp. 2.34% 180.00 2.86%
SAP SE 2.15% 205.40 0.58%
AstraZeneca PLC (DELISTED) 2.15% 187.10 2.15%
Autotrader Group Plc 2.07% 6.479 0.10%
Siemens AG 2.00% 303.31 -1.52%
KDDI Corp. 1.99% 17.04 0.00%
Capcom Co., Ltd. 1.98% 22.34 0.00%
Novartis AG 1.98% 161.50 2.22%
Novo Nordisk A/S 1.97% 49.75 -0.43%

Fees & Availability

Fees
Actual 12B-1 Fee --
Actual Management Fee --
Administration Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
General Availability
Available for Insurance Product No
Available for RRSP Yes
Purchase Details
Open to New Investors Yes
Minimum Initial Investment 500.00 None
Minimum Subsequent Investment 25.00 None

Basic Info

Investment Strategy
The Fund seeks a similar return to its underlying fund, which is also managed by Fidelity, by investing substantially all of its assets in securities of that underlying fund. The underlying fund seeks to replicate, to the extent reasonably possible and before fees and expenses, the performance of the Fidelity Canada International High Quality Index. The underlying fund invests primarily in equity securities of large and mid-capitalization foreign companies that have their principal business activities or interests outside of Canada or the U.S. with a higher quality profile than the broader developed international equity market.
General
Security Type Mutual Fund
Equity Style Multi Cap Growth
Broad Asset Class International Equity
Broad Category Equity
Global Peer Group Equity Global ex US
Peer Group International Equity
Global Macro Equity Global
US Macro --
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective --
Fund Owner Firm Name Fidelity Investments
Broad Asset Class Benchmark Index
^SPTSX60TR 100.0%

View Basic Info
Start Trial

Fundamentals

General
Distribution Yield --
Dividend Yield TTM (2-13-26) 1.06%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings 119
Stock
Weighted Average PE Ratio 27.64
Weighted Average Price to Sales Ratio 6.755
Weighted Average Price to Book Ratio 8.438
Weighted Median ROE 111.7%
Weighted Median ROA 15.67%
ROI (TTM) 24.86%
Return on Investment (TTM) 24.86%
Earning Yield 0.0444
LT Debt / Shareholders Equity 0.5374
Number of Equity Holdings 90
As of December 31, 2025

Growth Metrics

EPS Growth (1Y) 16.98%
EPS Growth (3Y) 18.23%
EPS Growth (5Y) 18.39%
Sales Growth (1Y) 11.17%
Sales Growth (3Y) 10.12%
Sales Growth (5Y) 9.22%
Sales per Share Growth (1Y) 12.45%
Sales per Share Growth (3Y) 11.29%
Operating Cash Flow - Growth Rate (3Y) 13.07%
As of December 31, 2025

Fund Details

Key Dates
Launch Date 1/24/2019
Share Classes
FID6542 Commission-based Advice
FID7564 Commission-based Advice
FID7565 Fee-based Advice
Attributes
Inverse Fund No
Leveraged Fund --
Currency Hedged Fund --
Socially Responsible Fund No

Top Portfolio Holders

Name % Weight
Portfolio A 5.00%
Portfolio B 3.50%
Portfolio C 2.25%
View Top Portfolio Holders
Start Trial

Excel Add-In Codes

Name: =YCI("M:FID6543.TO", "name")
Broad Asset Class: =YCI("M:FID6543.TO", "broad_asset_class")
Broad Category: =YCI("M:FID6543.TO", "broad_category_group")
Prospectus Objective: =YCI("M:FID6543.TO", "prospectus_objective")
To find the codes for any of our securities and financial metrics, see our Complete Excel Reference.
View Excel Add-In Codes
Start Trial